InterAx Biotech

InterAx Biotech Overview

Status Private
Latest Deal Type Series A
Latest Deal Amount $3.04M
Latest Deal Amount
Investors 4

InterAx Biotech General Information

Description

Owner and operator of a biotechnology company. The company develops drug-screening packages using membrane and soluble protein for the pharmaceutical industry.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • C/o Paul Scherrer Institute
  • OFLG, 5232 Villigen PSI
  • Switzerland
+41 056 000 00 00

InterAx Biotech Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InterAx Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 15-Jan-2019 $3.04M 00.000 000.00 Completed Startup
2. Grant 20-Jun-2018 000.00 0000 Completed Startup
1. Accelerator/Incubator 01-Jan-2015 $30K $30K Completed Startup

InterAx Biotech Cap Table

To view InterAx Biotech‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 000,000 00.000000 00.00 00.00 00 00.00 00.000

InterAx Biotech Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Dianomi Therapeutics Angel-Backed Madison, WI 00 00.000 000000000000 00.000
000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
000000000 00000000 Formerly VC-backed Utrecht, Netherlands 00 00.00 000000&0 00.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00

InterAx Biotech Executive Team (1)

Name Title Board Seat Contact Info
Martin Ostermaier Co-Founder, Chief Executive Officer & Board Member

InterAx Biotech Board Members (1)

Name Representing Role Since
Martin Ostermaier InterAx Biotech Co-Founder, Chief Executive Officer & Board Member 000 0000

InterAx Biotech Investors (4)

To view InterAx Biotech‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Falcon III Ventures Venture Capital Minority 000 0000 000000 0
Investiere Venture Capital Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Venture Kick Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial